B

Bavarian Nordic
BAVA

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
DKK11.87B
EV
DKK9.85B
Shares Outstanding
77.81M
Beta
1.38

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
DKK270.50
P/E 2025E
9.58x
P/Revenue 2025E
1.83x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Bavarian Nordic A/S

gainify

B

Bavarian Nordic A/S

BAVA

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-b...

Sector

Healthcare

Industry

Biotechnology

CEO

Chaplin, Paul

Employees

1,605

IPO Date

2000-01-03

Headquarters

Philip Heymans Alle 3, Hellerup, Capital Region of Denmark, 2900, Denmark

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved